1
Return

Characterization of the genotypic and phenotypic spectrum of TCF7L2-related neurodevelopmental disorder (TRND)

delete2026-07-07
delete0
delete
OA
AI
S
Sally Nijim *
M
Mimi Kim
M
Melissa Denish
M
Michael V. Gonzalez
J
Joseph Zinski
C
Claudine Rieubland
D
Dominique Braun
E
Elsebet Østergaard
A
Amelle Shillington
L
Laurence Faivre
J
Julien Maraval
A
Aurore Garde
C
Christophe Philippe
F
Frederic Tran-Mau-Them
A
Amy Crunk
DOI:10.1016/j.gim.2026.102642delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
TCF7L2 (OMIM:602228; HGNC:11641) is a transcription factor and critical effector of the Wnt /β -Catenin pathway. In 2021, 11 pediatric patients with mono-allelic predicted loss-of-function (pLOF) TCF7L2 variants and syndromic features were observed. Characterization of patients with pLOF TCF7L2 variants and neurodevelopmental features – herein referred to as TCF7L2-related neurodevelopmental disorder (TRND) – is urgently needed.
Keywords:
TCF7L2
TCF7L2-related neurodevelopmental disorder (TRND)
neurodevelopmental syndrome
speech delay

Journal

Genetics in Medicine cover
Genetics in Medicine
IF:
6.2
Papers:
5.1K
Citations:
2.0W

Organization

No organization information available
Cited Papers

Cited Papers

Citing Papers

Citing Papers